Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Q BioMed Inc
QBIOCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.qbiomed.com
ISIN
US74736N1054
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
14 509 USD
Yield for 12 month
-90.00 %
1Y
3Y
5Y
10Y
15Y
QBIO
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York. Address: 366 Madison Avenue, New York, NY, United States, 10017
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+284 352 USD
Last Year
+195 597 USD
Current Quarter
–
Last Quarter
+2 500 USD
Current Year
-8 988 USD
Last Year
-51 249 USD
Current Quarter
–
Last Quarter
–
Key Figures QBIO
1 year
3 years
5 years
10 years
EBITDA
-2 676 170 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-85.13 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
6 USD
Revenue TTM
209 293 USD
Book Value
-0.087 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-88.1 %
Dividend Yield
–
Gross Profit TTM
-8 988 USD
Earnings per share
-0.02 USD
Diluted Eps TTM
-0.02 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-231.77 %
Dividend Analytics QBIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2.5:1
Payout Ratio
–
Last Split Date
07.08.2015
Dividend Date
–
Stock Valuation QBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
109.8901
Enterprise Value Revenue
44.2678
Price Sales TTM
0.0693
Enterprise Value EBITDA
11.4155
Price Book MRQ
330.4621
Financials QBIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QBIO
For 52 weeks
–
0.0012 USD
50 Day MA
0.0005 USD
Shares Short Prior Month
–
200 Day MA
0.0004 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart